SanaClis brings software solutions to DIA 2017
Press Release | SanaClis s.r.o.
JUNE 21, 2017
Bratislava, Slovakia: – Award-winning full service CRO SanaClis will return to the annual DIA 2017 in Chicago as an exhibitor. The SanaClis stand at booth 745 at McCormick Place presents the company’s own Software Solutions.
Visitors to the stand are able to experience the online tracking of IMP storage conditions and meet senior SanaClis leaders, including and Managing Partner, Member of the Board, Alexander Fetkovsky. Attendees will also receive promotional materials.
“We are a regular exhibitor at DIA annual meeting with a four-year history, one of the largest events gathering a global network of professionals involved in clinical trials,” said Mr. Fetkovsky.
SanaClis looks to network with pharma and biotech decision makers within clinical operations, clinical development, supply chain and data management in Chicago.
“Our aim is to demonstrate how we can provide best possible “cost-quality” solutions by using our own resources, own facilities and partnership synergies.” Alexander Fetkovsky explained.
“We can help open the door to EU for non-EU companies. At the same time we can open the door to post-Soviet countries (Ukraine, Russia, Belarus, Georgia etc.) which we are able to do with less vendors and lean structure.
SanaClis is a Slovakian-headquartered full service CRO supporting pharma and biotech companies for more than 15 years covering full cycle of Phase I-IV clinical trials under one roof. In addition to classical CRO services such as regulatory, clinical monitoring and project management, data management and biostatistics it also offers IMP management services mainly in Central and Eastern Europe via its network of GxP-compliant warehouses.
In 2012, SanaClis s.r.o. was rated positively by reputable business agency Creditreform and for 2013, 2014, 2015, 2016 was certified with the AA rating “High creditworthiness” by Bisnode rating agency. SanaClis has earned its place on Nice Insight’s survey of Top Ten lists of Clinical Research Organizations (CROs) for 2015, based on customer perceptions of quality.
SanaClis’ Chief Executive, Dr. Natalia Fetkovska, joined the ranks of the winners of BW’s annual CEO Awards 2016 in recognition for her work in taking SanaClis to become leading CRO in Central and Eastern Europe, recognizes for its reliability and professionalism.
This is the first time a Slovakian-headquartered CRO has finished among the leaders in CRO industry, reflecting intensive investments and quality assurance measures. In 2015, SanaClis was awarded with the CRO Leadership Award in the category Reliability. Moreover in 2015 SanaClis was awarded for Excellence in Drug Development – Europe & Best for Clinical Trials 2015. In 2016, SanaClis was rewarded with Award for Best Drug Development CRO 2016 – Europe & Award for Excellence in Clinical Trial Monitoring – Europe. Afterwards SanaClis was recognized by CV magazine and received Health Tech & Pharma Innovation Awards 2016 in the category Software.
About DIA 2017
The Drug Information Association (DIA) is a US-based membership organization dedicated to creating a trusted global environment in which health care product development professionals can share insights and drive action in health care product development and life cycle management.
The DIA Annual Meeting is the largest, longest-running event in the life sciences industry and attracts more than 7,000 DIA members from all over the world.
Themed “Driving Insights to Action,” DIA 2017 is a five-day event opening June 18 at the McCormick Place center in Chicago. It will play host to more than 450 exhibiting companies with a conference that features more than ten tracks and more than 160 sessions.
The event is organized by DIA with more information at: http://www.diaglobal.org/Flagship/DIA-2017
Svitlana Udubkova, BD manager, SanaClis
Tel: +42 191 811 6271